Recently Posted Guidance Documents

• 9/15/2020 - Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry
• 9/15/2020 - Geriatric Information in Human Prescription Drug and Biological Product Labeling Guidance for Industry
• 9/15/2020 - Recognition and Withdrawal of Voluntary Consensus Standards
• 9/14/2020 - Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment